Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 473 - Heterocyclic compounds containing purine ring systems
Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932)
11/2007
11/06/2007CA2353527C Use of neurotrophic factor stimulators for the treatment of ophthalmic neurodegenerative diseases
11/01/2007WO2007121919A1 Purine derivatives with activity to the adenosine a2a receptor
11/01/2007WO2007121918A2 Use of 2-(purin-9-yl)-tetrahydofuran-3,4-diol derivatives as adenosine a2a receptor agonists
11/01/2007WO2007121917A2 Purine derivatives as adenosine receptor activator
11/01/2007WO2007104053A3 8-heteroarylpurine mnk2 inhibitors for treating metabolic disorders
11/01/2007US20070254884 Compositions and Methods for Inducing Cell Dedifferentiation
11/01/2007US20070253896 7,9-Dihydro-Purin-8-One and Related Analogs as HSP90-Inhibitors
11/01/2007CA2649215A1 2,6,9-trisubstituted purine compounds as adenosine aza receptor modulators
11/01/2007CA2649211A1 Organic compounds
11/01/2007CA2649205A1 Organic compounds
11/01/2007CA2648810A1 Organic compounds
10/2007
10/31/2007EP1848718A1 Inhibitors of e1 activating enzymes
10/31/2007EP1848717A2 6-ether/thioether-purines as topoisomerase ii catalytic inhibitors and their use in therapy
10/31/2007EP1848697A2 Diketo acids with nucleobase scaffolds: anti-hiv replication inhibitors targeted at hiv integrase
10/31/2007EP1509525B9 Process for preparing xanthine phosphodiesterase v inhibitors and precursors thereof
10/31/2007EP1496896A4 Inhibitors of akt activity
10/31/2007DE60125750T2 Pharmazeutische formulierung enthaltend trägerkügelchen mit aufgebrachter schicht aus valaciclovir A pharmaceutical formulation comprising carrier beads made with an applied layer valaciclovir
10/31/2007CN101062037A Thioxanthine derivatives, process for their preparation (variants), their use and composition containing them
10/31/2007CN100345552C Enantiomerically pure beta-d-dioxolane nucleosides with selective anti-hepatitus b virus activity
10/30/2007CA2340214C Method of manufacture of 1,3-oxathiolane nucleosides
10/25/2007WO2007120538A1 Narcotine purification process
10/25/2007WO2007120454A1 Azolopyrimidines as inhibitors of cannabinoid 1 activity
10/25/2007WO2007120098A1 Thioxanthine derivatives and their use as inhibitors of mpo
10/25/2007WO2007120097A1 Thioxanthine derivatives and their use as inhibitors of mpo
10/25/2007WO2007073518A3 Compounds and methods for thiol-containing compound efflux and cancer treatment
10/25/2007WO2004094595A3 MODIFIED iRNA AGENTS
10/25/2007US20070249639 Use of 9H-Purine-2,6-Diamine Derivatives in the Treatment of Proliferative Diseases and Novel 9H-Purine-2,6-Diamine Derivatives
10/25/2007US20070249638 Derivatives of triazoly-imidazopyridine and of the triazolypurines useful as ligands of the adenosine A2a receptor and their use as medicaments
10/25/2007US20070249609 Benzoimidazolyl-pyrazine compounds for inflammation and immune-related uses
10/25/2007US20070249601 Compounds and therapeutical use thereof
10/25/2007US20070249598 selective antagonists of A2B adenosine receptors; for improving insulin sensitivity; asthma
10/25/2007US20070249548 Nucleoside Analog or Salts of the Same
10/25/2007CA2649150A1 Thioxanthine derivatives and their use as inhibitors of mpo
10/25/2007CA2649032A1 Narcotine purification process
10/24/2007EP1846408A1 5-membered annelated heterocyclic pyrimidines as kinase inhibitors
10/24/2007CN100344628C Pyrazopyrimidinone compounds and use thereof
10/23/2007US7285622 Hydrophilic polymer covalently yet reversibly linked to a amine-containing ligand through a dithiobenzyl linkage; modification of various substrates, such as polypeptides
10/23/2007US7285558 Helicobacter infections; bactericides
10/23/2007CA2217780C Polyether nucleic acids
10/18/2007WO2007084415A3 Compounds for the treatment of inflammatory disorders
10/18/2007US20070244134 Selective antagonists of A2A adenosine receptors
10/18/2007US20070244114 Compounds and therapeutical use thereof
10/18/2007US20070244113 Compounds and therapeutical use thereof
10/18/2007US20070243568 Specific Substrates for O6-Alkylguanine-Dna Alkyltransferase
10/17/2007CN101056879A Purine derivatives as A3 and A1 adenosine receptor agonists
10/17/2007CN101054378A Entikawei potassium used for curing acute and chronic hepatic disease and preparation method thereof
10/11/2007WO2007092213A3 Inhibitors of e1 activating enzyme
10/10/2007EP1841769A2 Purine derivatives compositions containing the same and use thereof against cancer
10/10/2007EP1841768A1 Purine derivatives acting as a2a receptor agonists
10/10/2007EP1624897B1 Hiv prodrugs cleavable by cd26
10/10/2007CN101052394A Treatment of acute myeloid leukemia with indolinone compounds
10/10/2007CN101050216A Method for synthesizing medication Entecavir of anti hepatitis B
10/09/2007US7279483 Famciclovir monohydrate
10/09/2007US7279482 Such as 6-(2-hydroxy-3-chloroxybenzylamino)purine, 6-(2-hydroxy-4-chlorobenzylamino)purine; agriculture; cloning; immunostimulation
10/04/2007WO2007110637A1 Method for extracting target alkaloid using an ionic liquid as extracting solvent
10/04/2007US20070232626 Purine Derivatives as A3 and A1 Adenosine Receptor Agonists
10/04/2007CA2680789A1 Heterocyclic compounds and uses thereof in the treatment of sexual disorders
10/03/2007EP1838710A1 Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith
10/03/2007CN101048410A HIV inhibiting bicyclic pyrimidine derivatives
10/03/2007CN101048409A Method for producing chiral 8-(3-amino-piperidin-1-yl)-xanthines
10/03/2007CN101048408A Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
10/02/2007US7276248 Conjugate having a cleavable linkage for use in a liposome
10/02/2007CA2176376C Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 6 infections
09/2007
09/27/2007WO2007109362A2 Benzoimidazolyl-parazine compounds for inflammation and immune-related uses
09/27/2007US20070225305 Preparation of ester of purine derivatives
09/27/2007US20070225304 Aminopurine derivatives for treating neurodegenerative diseases
09/27/2007US20070225303 8-Oxoadenine Compound
09/27/2007US20070225302 2-Amino-9-[(2-hydroxymethyl) cyclopropylidenemethyl] purines as antiviral agents
09/27/2007CA2646124A1 Pharmaceutically acceptable salts and polymorphic forms
09/26/2007EP1837336A1 Preparation of valganciclovir
09/26/2007EP1837033A1 REMEDY FOR DIABETES CONTAINING Cdk5 INHIBITOR
09/26/2007CN101044142A 嘌呤衍生物 Purine derivatives
09/26/2007CN101044141A Purine derivatives for use as adenosin A-2A receptor agonists
09/26/2007CN101044122A Methods to manufacture 1,3-dioxolane nucleosides
09/26/2007CN100339080C Antiviral compounds
09/25/2007US7273864 inducing in vivo and in vitro differentiation and transdifferentiation of mammalian cells into cells of an osteoblast lineage
09/25/2007CA2388176C Therapeutic agent for eating disorders
09/21/2007CA2581965A1 Preparation of ester of purine derivatives
09/20/2007WO2007106192A2 Inhibitors of iap
09/20/2007WO2007105023A1 Modulation of phosphoryl transferase activity of glutamine synthetase
09/20/2007WO2007024707A3 Tlr agonists
09/20/2007US20070219223 Compositions and methods for treating respiratory disorders
09/20/2007US20070219220 Pyrazolopyrimidinethione Derivatives, Salts and Solvates Thereof, Preparation Methods and Use Thereof
09/19/2007EP1833823A1 2,5- and 2,6-disubstituted benzazole analogues useful as protein kinase inhibitors
09/19/2007CN100338040C Xanthine oxidase inhibitors
09/18/2007US7271157 Contacting (4S,2R,3R,5R)-2-(6-chloropurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol with a protected (2-hydroxy) cyclopentylamine compound having a protecting group on the 2-hydroxy moiety;contacting=with thionyl chloride in the presence of a second base;contacting with base, removing protecting group
09/18/2007CA2144477C Pna synthesis using an amino protecting group which is labile to weak acids
09/13/2007WO2007104053A2 8-heteroarylpurine mnk2 inhibitors for treating metabolic disorders
09/13/2007WO2007103970A2 Compositions and methods for treating respiratory disorders
09/13/2007WO2006002846A3 New analogs of nitrobenzylthioinosine
09/13/2007US20070213362 2-nh-heteroarylimidazoles with antibacterial activity
09/13/2007US20070213316 N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives
09/13/2007CA2646429A1 8-heteroarylpurine mnk2 inhibitors for treating metabolic disorders
09/13/2007CA2644613A1 Compositions and methods for treating respiratory disorders
09/12/2007EP1648894B1 Method for the production of oh protected [4-(2.6-diamino-9h-purine-9-yl)- 1.3-dioxolane-2-yl]methanol derivatives
09/11/2007US7268141 Xanthine phosphodiesterase V inhibitors
09/06/2007US20070208181 reduced or no emetogenic effects ; benzylated phosphodiesterase 4 inhibitors; e.g. Rolipram, Ariflo, Arofylline; preparation by benzylation using benzyl bromide or a derivative; antiinflammatory agents; to treat autoimmune diseases; cystic fibrosis
09/06/2007US20070208044 Compounds and therapeutical use thereof
09/06/2007US20070208036 Arylalkanes, arylalkenes and aryl-azaalkanes, pharmaceutical compositions containing these compounds and processes for preparing them
09/06/2007US20070207978 Stimulate mammalian coronary vasodilatation; imaging the heart; antiinflammatory; adjunctive therapy with angioplasty; platelet aggregation inhibitor; inhibitor of platelet and neutrophil activation;
1 ... 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 ... 120